LAKSHMI NAIR: Open Payments
NPI 1720588742 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,481 in 88 payments from 14 companies in 2025. Trend: 2023 $171 · 2024 $1,215 · 2025 $22,481
Speaker / faculty: $17,820Travel & lodging: $2,507Food & beverage: $2,154
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 28 | $21,181 |
| ABBVIE INC. | 26 | $444 |
| E.R. Squibb & Sons, L.L.C. | 2 | $153 |
| Neurocrine BioSciences, Inc. | 6 | $151 |
| Lundbeck LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Braeburn Inc. | 3 | $68 |
| Corium, LLC | 5 | $67 |
| Indivior Inc. | 2 | $67 |
| Janssen Scientific Affairs, LLC | 1 | $60 |
Products named: INVEGA SUSTENNA, VRAYLAR, COBENFY, INGREZZA, REXULTI, CAPLYTA, BRIXADI, Azstarys.
Industry payments across AZ — which companies pay providers there.
